These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20192903)

  • 21. High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
    Haraszti RA; Didiot MC; Sapp E; Leszyk J; Shaffer SA; Rockwell HE; Gao F; Narain NR; DiFiglia M; Kiebish MA; Aronin N; Khvorova A
    J Extracell Vesicles; 2016; 5():32570. PubMed ID: 27863537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood/plasma secretome and microvesicles.
    Inal JM; Kosgodage U; Azam S; Stratton D; Antwi-Baffour S; Lange S
    Biochim Biophys Acta; 2013 Nov; 1834(11):2317-25. PubMed ID: 23590876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.
    Hewitt NJ; Lechón MJ; Houston JB; Hallifax D; Brown HS; Maurel P; Kenna JG; Gustavsson L; Lohmann C; Skonberg C; Guillouzo A; Tuschl G; Li AP; LeCluyse E; Groothuis GM; Hengstler JG
    Drug Metab Rev; 2007; 39(1):159-234. PubMed ID: 17364884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microvesicles as promising biological tools for diagnosis and therapy.
    Panfoli I; Santucci L; Bruschi M; Petretto A; Calzia D; Ramenghi LA; Ghiggeri G; Candiano G
    Expert Rev Proteomics; 2018 Oct; 15(10):801-808. PubMed ID: 30253662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocytes: the powerhouse of biotransformation.
    Sevior DK; Pelkonen O; Ahokas JT
    Int J Biochem Cell Biol; 2012 Feb; 44(2):257-61. PubMed ID: 22123318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The regulation of human hepatic drug transporter expression by activation of xenobiotic-sensing nuclear receptors.
    Amacher DE
    Expert Opin Drug Metab Toxicol; 2016 Dec; 12(12):1463-1477. PubMed ID: 27548410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
    Xu C; Li CY; Kong AN
    Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xenobiotic metabolizing enzymes of the kidney.
    Lock EA; Reed CJ
    Toxicol Pathol; 1998; 26(1):18-25. PubMed ID: 9502382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microvesicles and intercellular communication in the context of parasitism.
    Barteneva NS; Maltsev N; Vorobjev IA
    Front Cell Infect Microbiol; 2013; 3():49. PubMed ID: 24032108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
    Schulz C; Kammerer S; Küpper JH
    Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In situ sites for xenobiotic activation and detoxication: implications for the differential susceptibility of cells to the toxic actions of environmental chemicals.
    Baron J
    Prog Histochem Cytochem; 1991; 23(1-4):32-44. PubMed ID: 1947157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does hepatic steatosis affect drug metabolizing enzymes in the liver?
    Buechler C; Weiss TS
    Curr Drug Metab; 2011 Jan; 12(1):24-34. PubMed ID: 21222589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the thrombotic and fibrinolytic activities of tumor cell-derived extracellular vesicles.
    Durrieu L; Bharadwaj A; Waisman DM
    Blood Adv; 2018 May; 2(10):1054-1065. PubMed ID: 29752284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.
    Niwa T; Murayama N; Yamazaki H
    Curr Drug Metab; 2009 Sep; 10(7):700-12. PubMed ID: 19594405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery.
    Principe S; Hui AB; Bruce J; Sinha A; Liu FF; Kislinger T
    Proteomics; 2013 May; 13(10-11):1608-23. PubMed ID: 23505015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone Marrow Mesenchymal Stem Cell-Derived Hepatocyte-Like Cell Exosomes Reduce Hepatic Ischemia/Reperfusion Injury by Enhancing Autophagy.
    Yang B; Duan W; Wei L; Zhao Y; Han Z; Wang J; Wang M; Dai C; Zhang B; Chen D; Chen Z
    Stem Cells Dev; 2020 Mar; 29(6):372-379. PubMed ID: 31969065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-dependent metabolism of xenobiotics.
    Mugford CA; Kedderis GL
    Drug Metab Rev; 1998 Aug; 30(3):441-98. PubMed ID: 9710703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. StAR-related lipid transfer domain 11 (STARD11)-mediated ceramide transport mediates extracellular vesicle biogenesis.
    Fukushima M; Dasgupta D; Mauer AS; Kakazu E; Nakao K; Malhi H
    J Biol Chem; 2018 Sep; 293(39):15277-15289. PubMed ID: 30139741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subtoxic Alterations in Hepatocyte-Derived Exosomes: An Early Step in Drug-Induced Liver Injury?
    Holman NS; Mosedale M; Wolf KK; LeCluyse EL; Watkins PB
    Toxicol Sci; 2016 Jun; 151(2):365-75. PubMed ID: 26962055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rat hepatocyte cultures and co-cultures in biotransformation studies of xenobiotics.
    Rogiers V; Vercruysse A
    Toxicology; 1993 Oct; 82(1-3):193-208. PubMed ID: 8236274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.